Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA114859
Max Phase: Preclinical
Molecular Formula: C33H50O8
Molecular Weight: 574.76
Molecule Type: Small molecule
Associated Items:
ID: ALA114859
Max Phase: Preclinical
Molecular Formula: C33H50O8
Molecular Weight: 574.76
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCC[C@@]1(OC)CC[C@]2(CC[C@H](C)[C@@H](C/C=C(C)/C=C/[C@H](O)[C@@H](C)/C=C/C(=O)O)O2)O[C@H]1/C=C/C(C)=C/C(=O)O
Standard InChI: InChI=1S/C33H50O8/c1-7-8-18-32(39-6)20-21-33(41-29(32)15-11-24(3)22-31(37)38)19-17-26(5)28(40-33)14-10-23(2)9-13-27(34)25(4)12-16-30(35)36/h9-13,15-16,22,25-29,34H,7-8,14,17-21H2,1-6H3,(H,35,36)(H,37,38)/b13-9+,15-11+,16-12+,23-10+,24-22+/t25-,26-,27-,28+,29-,32+,33-/m0/s1
Standard InChI Key: HLGCQPMVAUVQRL-LTPNEUAOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 574.76 | Molecular Weight (Monoisotopic): 574.3506 | AlogP: 6.37 | #Rotatable Bonds: 14 |
Polar Surface Area: 122.52 | Molecular Species: ACID | HBA: 6 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.04 | CX Basic pKa: | CX LogP: 6.32 | CX LogD: 0.55 |
Aromatic Rings: 0 | Heavy Atoms: 41 | QED Weighted: 0.16 | Np Likeness Score: 1.92 |
1. Shimizu T, Usui T, Machida K, Furuya K, Osada H, Nakata T.. (2002) Chemical modification of reveromycin A and its biological activities., 12 (23): [PMID:12419362] [10.1016/s0960-894x(02)00782-5] |
2. Shimizu T, Usui T, Fujikura M, Kawatani M, Satoh T, Machida K, Kanoh N, Woo JT, Osada H, Sodeoka M.. (2008) Synthesis and biological activities of reveromycin A and spirofungin A derivatives., 18 (13): [PMID:18519164] [10.1016/j.bmcl.2008.05.054] |
Source(1):